Evidence map›Paper›PMID 22446383›Full record

ReviewAgeing research reviews2012

The role of CUGBP1 in age-dependent changes of liver functions.

Karlie Jones, Lubov Timchenko, Nikolai A Timchenko

Abstract readReview
In one paragraph

Review in Ageing research reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karlie JonesDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Lubov Timchenko
Nikolai A Timchenko
Baylor College of Medicine · US

Funding

Molecular Physiology of the Cardiovascular SystemT32HL007676 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI HAMILTON, SUSAN L · 1989 to 2020
$7.9M
Molecular Mechanisms of C/EBP Alpha Mediated Growth ArrestR01GM055188 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 1997 to 2013
$3.3M
Myotonic Dystrophy Type 2R01AR052791 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, LUBOV T · 2005 to 2015
$3.1M
Molecular mechanisms of Myotonic Dystrophy 1R01AR044387 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, LUBOV T · 1997 to 2012
$2.8M
Regulation of Cell Growth by RNA Binding ProteinsR01CA100070 · NCI · BAYLOR COLLEGE OF MEDICINE · PI TIMCHENKO, NIKOLAI A. · 2003 to 2012
$2.6M
Epigenetic Regulation of Cell and Tissue AgingR01AG032135 · NIA · BAYLOR COLLEGE OF MEDICINE · PI TIMCHENKO, NIKOLAI A. · 2007 to 2013
$1.8M
Role of Age in Liver CancerR01CA159942 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 2011 to 2015
$1.6M
Molecular Mechanisms of Longevity in Long-Lived MiceR01AG028865 · NIA · BAYLOR COLLEGE OF MEDICINE · PI DARLINGTON, GRETCHEN J. · 2007 to 2011
$1.5M
Testing the role of chromatin in healthspanR21AG039885 · NIA · BAYLOR COLLEGE OF MEDICINE · PI TIMCHENKO, NIKOLAI A. · 2011 to 2012
$353k
NCI NIH HHS CA100070NCI NIH HHS CA159942NCI NIH HHS R01 CA100070NCI NIH HHS R01 CA159942NHLBI NIH HHS HL007676NHLBI NIH HHS T32 HL007676NIAMS NIH HHS AR044387NIAMS NIH HHS AR052791NIAMS NIH HHS R01 AR044387NIAMS NIH HHS R01 AR052791NIA NIH HHS AG028865NIA NIH HHS AG039885NIA NIH HHS R01 AG028865NIA NIH HHS R01 AG032135NIA NIH HHS R21 AG039885NIGMS NIH HHS GM551888NIGMS NIH HHS R01 GM055188
6 · The paper itself

Abstract

Aging liver is characterized by alterations of liver biology and by a reduction of many functions which are important for the maintenance of body homeostasis. The main dysfunctions include appearance of enlarged hepatocytes, impaired liver regeneration after partial hepatectomy (PH), development of hepatic steatosis, reduction of secretion of proteins and alterations in the hepatic sinusoid. RNA binding proteins are involved in the regulation of gene expression in all tissues including regulation of biological processes in the liver. This review is focused on the role of a conserved, multi-functional RNA-binding protein, CUGBP1, in the development of aging phenotype in the liver. CUGBP1 has been identified as a protein which binds to RNA CUG repeats expanded in Myotonic Dystrophy type 1 (DM1). CUGBP1 is highly expressed in the liver and regulates translation of proteins which are critical for maintenance of liver functions. In livers of young mice, CUGBP1 forms complexes with eukaryotic translation initiation factor eIF2 and supports translation of C/EBPβ and HDAC1 proteins, which are involved in liver growth, differentiation and liver cancer. Aging changes several signaling pathways which lead to the elevation of the CUGBP1-eIF2α complex and to an increase of translation of C/EBPβ and HDAC1. These proteins form multi-protein complexes with additional transcription factors and with chromatin remodeling proteins causing epigenetic alterations of gene expression in livers of old mice. It appears that CUGBP1-mediated translational elevation of HDAC1 is one of the key events in the epigenetic changes in livers of old mice, leading to the development of age-associated dysfunctions of the liver. This review will also discuss a possible role of CUGBP1 in liver dysfunction in patients affected with DM1.

Indexed as

AgingAnimalsCELF1 ProteinConserved SequenceHumansLiver DiseasesMiceRNA-Binding ProteinsCELF1 ProteinCELF1 protein, mouseRNA-Binding Proteins

Identifiers

PMID22446383
PMCPMC3610417
OpenAlexW2086492668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.